Medina Embolization Framing Coil receives CE Mark for commercial distribution in Europe

Download PDF Copy

Sep 25 2014

Medina Medical announced today that it has received CE Mark (Conformitee Europeenne) authorization for its Embolization Framing Coil for commercial distribution in the European Union.

The Medina Embolization Framing Coil is used to treat brain aneurysms using minimally-invasive techniques, and is delivered like other embolization coils through a micro-catheter that has been threaded through blood vessels into the aneurysm. The novel Medina Embolization Framing Coil is designed to occupy space efficiently within an aneurysm.

"After three years dedicated to developing our product, we are so excited to be able to bring our technology to a broader group of patients. Helping patients is our passion. Seeing our technology play even a small part in the treatment of cerebral aneurysms, and knowing that we touched patients' lives is what drives us," commented Maria Aboytes, President and Co-Founder, Medina Medical, Inc.

"This is such an important milestone for the company. I am honored to be part of the success of this great organization," noted Erik T. Engelson, CEO, Medina Medical, Inc.

Source:

Medina Medical

Posted in: Device / Technology News | Medical Condition News

Comments (0)

Download PDF Copy

Suggested Reading

Wildfire smoke in late pregnancy may raise autism risk

Natural ovulation offers a safer path to IVF success

Study reveals how DKK3 triggers smooth muscle cell transformation in aortic aneurysm

Reading to young children each night improves empathy and creative thinking

Researchers open ‘window to the brain’ with powerful cancer tech

AI-powered wearable device could cut Parkinson’s care costs

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

The real resolution limit of the human eye

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.